Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use.

IF 2.4 3区 医学 Q3 PHARMACOLOGY & PHARMACY Experimental and clinical psychopharmacology Pub Date : 2024-02-01 Epub Date: 2023-05-25 DOI:10.1037/pha0000648
Victoria R Votaw, Cassandra L Boness, Elena R Stein, Ashley L Watts, Kenneth J Sher, Katie Witkiewitz
{"title":"Examining the validity of the addictions neuroclinical assessment domains in a crowdsourced sample of adults with current alcohol use.","authors":"Victoria R Votaw, Cassandra L Boness, Elena R Stein, Ashley L Watts, Kenneth J Sher, Katie Witkiewitz","doi":"10.1037/pha0000648","DOIUrl":null,"url":null,"abstract":"<p><p>Several dimensional frameworks for characterizing heterogeneity in alcohol use disorder (AUD) have been proposed, including the Addictions Neuroclinical Assessment (ANA). The ANA is a framework for assessing individual variability within AUD across three domains corresponding to the proposed stages of the addiction cycle: reward (binge-intoxication stage), negative emotionality (withdrawal-negative affect stage), and cognitive control (preoccupation-anticipation stage). Recent work has evaluated the ANA's three-factor structure and construct validity, primarily in treatment-seekers with AUD. We extended this research by examining the factor structure, bias across alcohol use severity, longitudinal invariance, and concurrent and predictive validity of a novel assessment of the ANA domains in adults with past 12-month regular (10 + alcohol units/week) alcohol use. Participants recruited from Prolific (<i>N</i> = 732), a crowdsourced data collection platform, completed various self-report measures. A test-retest subsample (<i>n</i> = 234) completed these measures 30 days later. Split-half exploratory factor analysis and confirmatory factor analysis supported the three-factor structure of the ANA. The overall factor structure was invariant across 30 days. Concurrently and prospectively, ANA domains demonstrated convergent validity concerning theoretically aligned alcohol-related, psychological, and personality measures. However, there was evidence of poor discriminant validity, and several cognitive control and reward items demonstrated bias across alcohol use severity. Future research is needed to improve the measurement of ANA domains using multimodal indicators, examine longitudinal changes in domains and their relationship with alcohol use severity, characterize phenotypic subgroups based on relative levels of domains, and compare the utility of the ANA with other proposed frameworks for measuring AUD heterogeneity. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11088344/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and clinical psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1037/pha0000648","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/5/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Several dimensional frameworks for characterizing heterogeneity in alcohol use disorder (AUD) have been proposed, including the Addictions Neuroclinical Assessment (ANA). The ANA is a framework for assessing individual variability within AUD across three domains corresponding to the proposed stages of the addiction cycle: reward (binge-intoxication stage), negative emotionality (withdrawal-negative affect stage), and cognitive control (preoccupation-anticipation stage). Recent work has evaluated the ANA's three-factor structure and construct validity, primarily in treatment-seekers with AUD. We extended this research by examining the factor structure, bias across alcohol use severity, longitudinal invariance, and concurrent and predictive validity of a novel assessment of the ANA domains in adults with past 12-month regular (10 + alcohol units/week) alcohol use. Participants recruited from Prolific (N = 732), a crowdsourced data collection platform, completed various self-report measures. A test-retest subsample (n = 234) completed these measures 30 days later. Split-half exploratory factor analysis and confirmatory factor analysis supported the three-factor structure of the ANA. The overall factor structure was invariant across 30 days. Concurrently and prospectively, ANA domains demonstrated convergent validity concerning theoretically aligned alcohol-related, psychological, and personality measures. However, there was evidence of poor discriminant validity, and several cognitive control and reward items demonstrated bias across alcohol use severity. Future research is needed to improve the measurement of ANA domains using multimodal indicators, examine longitudinal changes in domains and their relationship with alcohol use severity, characterize phenotypic subgroups based on relative levels of domains, and compare the utility of the ANA with other proposed frameworks for measuring AUD heterogeneity. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在当前酗酒成年人的众包样本中检验成瘾神经临床评估领域的有效性。
目前已提出了几种用于描述酒精使用障碍(AUD)异质性的维度框架,其中包括成瘾神经临床评估(ANA)。ANA 是一个框架,用于评估 AUD 在三个领域的个体差异性,这三个领域分别对应于所提出的成瘾周期阶段:奖赏(狂欢-中毒阶段)、负性情绪(戒断-负性情绪阶段)和认知控制(专注-预期阶段)。最近的研究对 ANA 的三因素结构和建构有效性进行了评估,主要是针对 AUD 的寻求治疗者。我们扩展了这一研究,对过去 12 个月经常饮酒(10 个酒精单位/周)的成年人进行了 ANA 领域的新评估,检验了其因子结构、不同饮酒严重程度的偏差、纵向不变性、并发和预测有效性。从众包数据收集平台 Prolific(N = 732)招募的参与者完成了各种自我报告测量。一个测试-重测子样本(n = 234)在 30 天后完成了这些测量。分半探索性因子分析和确认性因子分析支持 ANA 的三因子结构。总体因子结构在 30 天内保持不变。同时,ANA 的各个域在与酒精相关的理论、心理和人格测量方面表现出了前瞻性的趋同效度。但是,有证据表明其判别效度较差,而且几个认知控制和奖赏项目在不同的酒精使用严重程度下表现出偏差。未来的研究需要使用多模式指标改进 ANA 领域的测量,检查领域的纵向变化及其与酒精使用严重程度的关系,根据领域的相对水平描述表型亚组的特征,并比较 ANA 与其他建议的 AUD 异质性测量框架的效用。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.20
自引率
8.70%
发文量
164
审稿时长
6-12 weeks
期刊介绍: Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse.
期刊最新文献
Evaluating the human abuse potential of concurrent use of electronic cigarettes and low nicotine cigarettes among adults who smoke. Residual next-day effects of alprazolam on psychomotor performance and simulated driving in healthy normal adults. Efficacy and safety of balovaptan for posttraumatic stress disorder: A randomized, placebo-controlled trial. A behavioral choice analysis of the role of life events during early nonabstinent natural recovery from alcohol use disorder. An experimental investigation into the impact of acute stress on alcohol craving.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1